Literature DB >> 21857053

Sterile surgical helmet system in elective total hip and knee arthroplasty.

Vinay Kumar Singh1, Shazeena Hussain, Sadaf Javed, Ivor Singh, Rohinton Mulla, Yegappan Kalairajah.   

Abstract

PURPOSE: To evaluate the sterility of the sterile surgical helmet system (SSHS) during elective total hip and knee arthroplasty in theatres with (n=20) and without (n=20) laminar flow.
METHODS: Three surgeons performed 14 total knee arthroplasties (TKAs) and 6 total hip arthroplasties (THAs) in a laminar flow theatre and 15 TKAs and 5 THAs in a non-laminar flow theatre. An SSHS was used in all the procedures. Samples were taken from the hood at 30-minute intervals during surgery. Swabs were then broken into cooked meat broths for cultivation of organisms. The broths were then directly inoculated onto blood agar and fastidious anaerobic agar for culture of aerobic and anaerobic bacteria, respectively. After 24 hours, these plates were reinoculated with broths that had been incubated for 24 hours. Microbial growth was quantified as 0 (none), 1 (mild), 2 (moderate) and 3 (heavy). Bacterial contamination in the 2 groups at 30, 60 and 90 minutes was compared.
RESULTS: Respectively in the laminar and non-laminar flow theatres, 0 and 9 of the SSHSs showed bacterial growth after direct inoculation, and 14 and 18 of the SSHSs grew 18 and 24 types of organisms in the swab cultures after 24 hours of incubation. Respectively at 30, 60, and 90 minutes, the degree of contamination from direct incubation was significant, but the degree of contamination on swabs after 24 hours of inoculation was not significant. The mean time-dependent contamination after direct inoculation was 0 for the laminar flow group and 0.5, 0.75, and 1.0 for the non-laminar flow group, whereas the corresponding values after 24 hours of incubation were 1.8, 1.8, and 2.6, and 2, 2.75, and 2.95. Coagulase negative Staphylococcus aureus was the most common organism in both groups.
CONCLUSION: 80% of SSHSs used were contaminated intra-operatively. Direct contact with the SSHS should be avoided by the operating team during surgery. Routine changing of gloves in case of contact with the SSHS should be practised.

Entities:  

Mesh:

Year:  2011        PMID: 21857053     DOI: 10.1177/230949901101900222

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  7 in total

1.  Contamination Relative to the Activation Timing of Filtered-Exhaust Helmets.

Authors:  Andrew E Hanselman; Michael D Montague; Timothy R Murphy; Matthew J Dietz
Journal:  J Arthroplasty       Date:  2015-11-10       Impact factor: 4.757

2.  CORR Insights(®): The Gown-glove Interface Is a Source of Contamination: A Comparative Study.

Authors:  Sumon Nandi
Journal:  Clin Orthop Relat Res       Date:  2015-01-13       Impact factor: 4.176

3.  [Prevention of periprosthetic joint infections : Not evidence-based strategies].

Authors:  A Keshmiri; G Maderbacher; C Baier; H-R Springorum; J Grifka; J Schaumburger
Journal:  Orthopade       Date:  2015-05       Impact factor: 1.087

4.  Intraoperative contamination and space suits: a potential mechanism.

Authors:  Simon W Young; Carl Chisholm; Mark Zhu
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-02-09

5.  Method of intraoperative tissue sampling for culture has an effect on contamination risk.

Authors:  Antonia F Chen; Meredith Menz; Priscilla K Cavanaugh; Javad Parvizi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-09-12       Impact factor: 4.342

6.  Examination of Surgical Helmet and Surgical Hood Application Methods in Reducing Contamination in Arthroplasty Surgery.

Authors:  Laurant Kang; David Dewar; Abhirup Lobo
Journal:  Arthroplast Today       Date:  2021-01-30

7.  Efficacy of surgical helmet systems for protection against COVID-19: a double-blinded randomised control study.

Authors:  Gavin Schaller; Sandeep Krishan Nayar; Marios Erotocritou; Alexander Overton; Thomas Stelzhammer; Onur Berber
Journal:  Int Orthop       Date:  2020-09-08       Impact factor: 3.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.